Back to DE D. E. Shaw & Co., Inc.

IBRXIBRX
Showing 6 of 16 quarters

Position history for DED. E. Shaw & Co., Inc.'s holdings in IMMUNITYBIO INC

D. E. Shaw & Co., Inc. holds 11.6M shares of IBRX (IMMUNITYBIO INC), worth $101.1M as of 2026-Q2. The position was decreased (-8.1% shares). IBRX represents 0.0% of D. E. Shaw & Co., Inc.'s portfolio.

Current Value

$101.1M

Current Shares

11.6M

Total Value Change

+$99.2M

Total Shares Change

+11M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
11.6M
-8.1%
$101.1M0.0%$8.76
0
2026-Q1
New
12.6M
-
$96.4M0.1%$7.67
41
2025-Q3
Exited
0
-100.0%
$00.0%$2.46
0
2025-Q2
New
237,147
-
$626,0680.0%$2.64
34
2024-Q4
Exited
0
-100.0%
$00.0%$2.56
0
2024-Q3
New
520,053
-
$1.9M0.0%$3.72
36

Other major holders of IBRX: BlackRock, Inc., STATE STREET CORP, VANGUARD PORTFOLIO MANAGEMENT LLC, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used